What amount sold does Iberica Holdings LLC - Series 5 Manatus Bio report in Form D filings?

The latest linked filings report $250K sold across 1 identified offering(s). 1 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Iberica Holdings LLC - Series 5 Manatus Bio's most recent SEC filing?

Iberica Holdings LLC - Series 5 Manatus Bio's most recent Form D filing was on 2026-01-05.

How many investors does Iberica Holdings LLC - Series 5 Manatus Bio have?

The most recent Form D filing lists 1 investor(s).

Iberica Holdings LLC - Series 5 Manatus Bio

CIK: 0002049452·Pooled Investment Fund·GUAYNABO, PR

Reported Sold

$250,000

Total Filings

Identified Offerings

Last Filed

Jan 5, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 1 unlinked amendment excluded.

Offering filing timeline

Jan 5, 2026Form D/A — Amendment

Reported sold: $250,000 · Target: N/A

No verified predecessor available.

Rule 506(b)·1 investor·Section 3(c), Section 3(c)(1)

Dec 23, 2024Form D — New notice

Reported sold: $250,000 · Target: Indefinite

Rule 506(b)·1 investor·Section 3(c), Section 3(c)(1)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

50%

Latest reported sold across 1 identified offering

$250,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

1 unlinked amendment excluded.

Key People

Eduardo J Canto

Executive Officer, Promoter

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 5, 2026	Amendment	N/A	$250,000	1
Dec 23, 2024	New	Indefinite	$250,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Convex Venture Fund, LP - Series 11

Pooled Investment Fund

Offering target: Indefinite

Filed Oct 30, 2026